Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Oct 13, 2026

HKPD — Cellyan Biotechnology Co., Ltd Dilution Risk Tracker

Track HKPD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HKPD — Get alerts when the score changes →

As of October 13, 2026, Cellyan Biotechnology Co., Ltd (HKPD) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Cellyan Biotechnology Co., Ltd has a market capitalization of $1.75M, 16.35M shares outstanding, 4 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.61 below $1 exchange minimum
🔔 Track HKPD — Get forecast alerts →

Market Data

Market Cap$1.75M
Shares Outstanding16.35M
Float7.36M
Cash$2.48M
Debt$2.27M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore44/100DilutionWatch score record
Shares Outstanding16.35MVerified float table or market cache
Public Float7.36MVerified float table or market cache
Market Cap$1.75MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 15.3% shares (2026Q1 vs prior)
4 institutional holders · 62.4K shares
#1 StoneX Group Inc. 39.4K shares
#2 Clear Street Group Inc. 12.0K shares
#3 TWO SIGMA INVESTMENTS, LP 10.8K shares
+ 1 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest67.1K
Days to Cover1.0
% of Float0.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

HKPD's DilutionScore is currently 44/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 42/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202644/100MEDIUM53 days
Jul 16 – Aug 21, 202642/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track HKPD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment HKPD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking HKPD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for HKPD
HKPD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.